| Product Name | BCR-ABL Genotyping Qualitative Test Kit (Fluorescent PCR) |
| Catalog No. | BDDK-HMM-0024 |
| Description | Ph chromosome or BCR/ABL1 b2a2 and b3a2 phenotypes have become the main diagnostic criteria for CML, with ela2 predominantly seen in ALL. The b3a2 type is found in 55% of CML cases and b2a2 in 40%. In 5% of cases both b3a2 and b2a2 type spliceosomes are present. In addition, the BCR/ABL1 fusion gene type e19a2 is present in a very small number of Ph+ CML patients, the BCR/ABL1 fusion gene is type P210 in 30-50% of adult Ph+ ALL, 20-30% of pediatric Ph+ ALL cases, and in 60% of Ph+ ALL patients the BCR/ABL1 fusion gene is type P190. |
| Disease Type | Leukaemia |
| Applications | This kit can be used to qualitatively detect BCR-ABL1 fusion gene P190, P210, P230 types by fluorescence quantitative PCR technology. |
| Sample Type | Peripheral blood |
| Detection Methods | Fluorescent PCR Method |
| Storage | -20°C |
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
